ICD-10 Coding for Vulvovaginal Atrophy(N76.89, N76.89B, N76.89O)
Comprehensive guide on ICD-10 coding for vulvovaginal atrophy, including postmenopausal and non-postmenopausal cases. Learn about documentation requirements and common coding pitfalls.
Complete code families applicable to Vulvovaginal Atrophy
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| N95.2 | Postmenopausal atrophic vaginitis | Use when the patient is postmenopausal and presents with symptoms of vaginal atrophy. |
|
| N76.89 | Other specified inflammation of vagina and vulva | Use for atrophic vaginitis in non-postmenopausal patients. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutVulvovaginal Atrophy
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Vulvovaginal Atrophy.
Omitting menopausal status
Impact
Clinical: Misdiagnosis risk., Regulatory: Non-compliance with coding standards., Financial: Potential reimbursement issues.
Mitigation
Always verify and document menopausal status., Use templates that prompt for this information.
Coding non-postmenopausal atrophy as N95.2
Impact
Reimbursement: May lead to incorrect reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data.
Mitigation
Verify menopausal status before coding.
Menopausal Status Documentation
Impact
Failure to document menopausal status can lead to audit issues.
Mitigation
Implement mandatory fields in EHR for menopausal status.